Effects of Intermittent Fasting on Patients with Immune Thrombocytopenia (ITP) Receiving TPO-RA : Multicenter Mixed-Design Study

被引：0
|
作者：
Yassin, Mohamed A. [1 ]
Al-Rasheed, Mona [2 ]
Al-Eisa, Taghred [3 ]
Al-Hashim, Nora [4 ]
Al Sayegh, Faisal [4 ]
Abu Zaid, Tarek [5 ]
Musa, Heba [6 ]
Alshurafa, Awni [7 ]
Abdelfattah, Mohamed [8 ]
机构：
[1] Natl Ctr Canc Care & Res, Hematol BMT, Doha, Qatar
[2] Hematol Adan Hosp, Kuwait, Kuwait
[3] Jahra Hosp, Hematol Sect, Kuwait, Kuwait
[4] Mubarak Hosp, Hematol, Kuwait, Kuwait
[5] Al Mowasat Hosp, Hematol, Riyadh, Saudi Arabia
[6] Accsight, Cairo, Egypt
[7] Natl Ctr Canc Care Res, Dept Hematol & Bone Marrow Transplant, Doha, Qatar
[8] Accsight, Jeddah, Saudi Arabia
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182824
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 36 条
  • [31] Eltrombopag As Second Line Therapy in Adult Patients with Primary Immune Thrombocytopenia (ITP) in Attempt to Achieve Long-Term Remission. Preliminary Analysis of a Phase II, Multicenter, Prospective Study By Gimema Group (the ESTIT Study)
    Lucchini, Elisa
    Palandri, Francesca
    Volpetti, Stefano
    Vianelli, Nicola
    Auteri, Giuseppe
    Rossi, Elena
    Patriarca, Andrea
    Carli, Giuseppe
    Barcellini, Wilma
    Tosi, Patrizia
    Consoli, Ugo
    Valeri, Federica
    Santoro, Cristina
    Paoloni, Francesca
    Fazi, Paola
    Boggio, Elena
    Dianzani, Umberto
    Giardini, Ilaria
    Carpenedo, Monica
    Fanin, Renato
    Zaja, Francesco
    BLOOD, 2018, 132
  • [32] RESPONSE RATE AND RESPONSE DURATION AFTER DISCONTINUATION OF TREATMENT WITH THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RAS) IN PATIENTS AFFECTED BY PRIMARY IMMUNE THROMBOCYTOPENIA (PITP): RETROSPECTIVE STUDY. PRELIMINARY RESULTS. GIMEMA PROTOCOL ITP0714
    Mazzucconi, M. G.
    Santoro, C.
    Paoloni, F.
    Carpenedo, M.
    De Stefano, V.
    Cantoni, S.
    Vianelli, N.
    Iodice, M.
    Baldacci, E.
    Zaja, F.
    Bosi, A.
    Schinco, P.
    Fazi, P.
    Rodeghiero, F.
    HAEMATOLOGICA, 2019, 104 : 57 - 57
  • [33] Results From a Phase IV Open-Label Study Evaluating Changes In Bone Marrow Morphology In Adult Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim Analysis Of The 1-and 2-Year Romiplostim Cohorts
    Janssens, Ann
    Rodeghiero, Francesco
    Anderson, David
    Chong, Beng
    Boda, Zoltan
    Pabinger, Ingrid
    Cervinek, Libor
    Wang, Xuena
    BLOOD, 2013, 122 (21)
  • [34] Final Results from a Phase 4 Open-Label 3-Year Study Evaluating Changes in Bone Marrow (Bm) Morphology in Adult Immune Thrombocytopenia (ITP) Patients (Pts) Receiving the Thrombopoietin Mimetic Romiplostim
    Janssens, Ann
    Rodeghiero, Francesco
    Anderson, David
    Chong, Beng
    Boda, Zoltan
    Pabinger, Ingrid
    Cervinek, Libor
    Wang, Xuena
    Lopez, Angela
    BLOOD, 2014, 124 (21)
  • [35] Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study
    Martín J. García-González
    Manuel de Mora-Martín
    Silvia López-Fernández
    Javier López-Díaz
    Manuel Martínez-Sellés
    José Romero-García
    Marco Cordero
    Antonio Lara-Padrón
    Francisco Marrero-Rodríguez
    M. del Mar García-Saiz
    Ana Aldea-Perona
    Cardiovascular Drugs and Therapy, 2013, 27 : 573 - 579
  • [36] Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study
    Garcia-Gonzalez, Martin J.
    de Mora-Martin, Manuel
    Lopez-Fernandez, Silvia
    Lopez-Diaz, Javier
    Martinez-Selles, Manuel
    Romero-Garcia, Jose
    Cordero, Marco
    Lara-Padron, Antonio
    Marrero-Rodriguez, Francisco
    del Mar Garcia-Saiz, M.
    Aldea-Perona, Ana
    CARDIOVASCULAR DRUGS AND THERAPY, 2013, 27 (06) : 573 - 579
1234